Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics
The European Commission yesterday complemented the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'. Yesterday's Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.
It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.
The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:
- Research, development and innovation
- Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
- Set up a ‘therapeutics innovation booster' by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
- Access to and swift approval of clinical trials
- Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
- Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
- Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
- Scanning for candidate therapeutics
- Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
- Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
- Supply chains and delivery of medicines
- Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
- Regulatory flexibility
- Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
- Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
- Joint procurement and financing
- Launch new contracts for the purchase of authorised therapeutics by the end of the year.
- Secure faster access to medicines with shorter administrative deadlines.
- International cooperation to make medicines available to all
- Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
- Boost ‘OPEN' initiative for international collaboration.
Latest News from
Talent Partnerships: Commission launches new initiative to address EU skills shortages and improve migration cooperation with partner countries11/06/2021 16:33:00
Today, the Commission is launching Talent Partnerships, a key initiative under the New Pact on Migration and Asylum that will help to address skills shortages in the European Union and to strengthen mutually-beneficial partnerships on migration with third countries.
Central America and Mexico: EU reaffirms support with €18.5 million in humanitarian and development aid11/06/2021 15:25:00
The EU yesterday announced at the 'Solidarity event for forcibly displaced persons and host communities in Central America and Mexico', that it will allocate €18.5 million in aid. Of this sum, €12 million represents humanitarian funding to Central America, and €6.5 million constitutes development assistance.
Council endorses new EU strategy on adaptation to climate change11/06/2021 14:38:00
The Council yesterday approved conclusions endorsing a new strategy that outlines a long-term vision for the EU to become a climate-resilient society that is fully adapted to the unavoidable impacts of climate change by 2050.
Child Labour: Statement by the European Commission and the High Representative on the World Day against Child Labour11/06/2021 13:25:00
Child Labour: Statement given by the European Commission and the High Representative on the World Day against Child Labour.
Education: EU increases its commitment to Global Partnership for Education with a pledge of €700 million for 2021-202711/06/2021 12:38:00
Ahead of the G7 Summit, President of the European Commission Ursula von der Leyen yesterday announced that the European Union is pledging €700 million for the Global Partnership for Education (GPE) to help transform education systems for more than one billion girls and boys in up to 90 countries and territories.
EU external action budget: European Commission welcomes the final adoption of the EU's new long-term external action budget for 2021-202711/06/2021 11:33:00
The European Commission welcomes the European Parliament's decision to adopt the Neighbourhood, Development and International Cooperation Instrument (NDICI) – ‘Global Europe' for the period 2021-2027.
Speech by President von der Leyen at the European Parliament Plenary on the conclusions of the special meeting of the European Council of 24-25 May 2021 and preparation of the G7 Summit of 11-13 June 2021 and the EU-U.S. Summit11/06/2021 10:38:00
Speech given recently (09 June 2021) by President von der Leyen at the European Parliament Plenary on the conclusions of the special meeting of the European Council of 24-25 May 2021 and preparation of the G7 Summit of 11-13 June 2021 and the EU-U.S. Summit.
Report by President Charles Michel to the European Parliament plenary session11/06/2021 09:25:00
Hijacking a plane is piracy. With 171 passengers on board, it is kidnapping. When these acts are carried out by the state, it’s hostage-taking and state piracy.
Sustainable fisheries: Commission takes stock of progress in the EU and launches consultation on fishing opportunities for 202210/06/2021 16:33:00
The Commission yesterday adopted the Communication “Towards more sustainable fishing in the EU: state of play and orientations for 2022”.
EU citizens' electoral rights: Commission decides to refer CZECHIA and POLAND to the Court of Justice10/06/2021 15:25:00
The European Commission yesterday decided to refer Czechia and Poland to the Court of Justice, because in these two Member States EU citizens are restricted from joining a domestic political party.